Functioning artificial kidney on the way
|
Tweet
|
|
Using nanotechnology, researchers have taken the first step toward developing a fully functioning artificial kidney for patients with end-stage renal disease, possibly eliminating the need for dialysis or kidney transplantation. The device is small—about the size of a paperback book—and therefore portable or implantable.
In the journal Hemodialysis International, Dr. Allen R. Nissenson, from the University of California at Los Angeles, and colleagues note that the equipment consists of two membranes operating in series within one cartridge. The membranes mimic filter structures found in a real kidney.
As Nissenson told, “a connection to the bloodstream is necessary, which allows blood to flow into the device. In the device, it is filtered and processed by the membranes, with waste and water being discharged into a bag—the external bladder—to be discarded, and important substances like salt, calcium, and nutrients returned to the body.” In its final form, the device would operate continuously, imitating natural kidneys. No dialysis solution is used.
Using computer modeling, the researchers found that the device, operating 12 hours per day, 7 days per week, actually provides a greater filtering rate than conventional dialysis given three times a week.
In the United States, more than a third of people with end-stage renal disease have diabetes, and diabetic nephropathy (renal disease due to diabetes) is the leading cause of end-stage renal disease. Up to 40 percent of all people with type 1 (insulin-dependent or juvenile) diabetes eventually develop end-stage renal disease. Kidney disease also can develop in people with type 2 (non-insulin-dependent or adult-onset) diabetes. With either type, poor control of blood sugar increases the risk of end-stage renal disease.
Nissenson emphasized that work on the artificial kidney is “now just past the conceptual phase. We have done extensive computer modeling to predict how the device should work, and we have begun to construct the necessary membranes.”
“Future work,” he added, “involves producing a complete membrane, incorporating it into the device, and testing the function on animals, before human trials can begin. This next phase of work is expected to take 2 to 4 years, with clinical work possibly starting by 2010” he said.
SOURCE: Hemodialysis International, September 2005.
Revision date: June 22, 2011
Last revised: by Dave R. Roger, M.D.
| RELATED STORIES: | ||
| Comments | [ + Post Your Own ] |
Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.
There are no comments for this entry yet. [ + Comment here + ]
We are pleased to let readers post comments about an article. Please increase the credibility of your post by including your full name and email.
All comments are reviewed by our editors before they are posted on the site. Just keep it clean, kids.
- Full Story - - »»»
UN: Fukushima workers’ deaths not from radiation
- Full Story - - »»»
Childhood cancer effects may linger in adults
- Full Story - - »»»
Scientists turn skin cells into beating heart muscle
- Full Story - - »»»
Too many people get angioplasties, study suggests
- Full Story - - »»»
Viewers’ family background affects how they react to MTV shows ‘16 and Pregnant,’ ‘Teen Mom’
- Full Story - - »»»
Weight management in pregnancy with diet is beneficial and safe and can reduce complications
- Full Story - - »»»

